Parameters . | Univariable . | Multivariable . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Age (ref. <70 years) | ||||||
≥70 | 1.14 | 0.71–1.76 | 0.563 | |||
Gender (ref. male) | ||||||
Female | 0.82 | 0.54–1.20 | 0.300 | |||
Histological type (ref. LG-TC) | ||||||
HG-TC | 1.35 | 0.65–2.49 | 0.391 | |||
NOS-TC | 1.20 | 0.73–1.88 | 0.446 | |||
Resection status (ref. R2 non-resection) | ||||||
R0 | 0.16 | 0.09–0.28 | <0.001 | 0.27 | 0.15–0.48 | <0.001 |
R1 | 0.42 | 0.23–0.77 | <0.001 | 0.40 | 0.22–0.74 | 0.004 |
R2 sub-total | 0.43 | 0.22–0.81 | <0.001 | 0.38 | 0.20–0.72 | 0.003 |
Pathological Masaoka stage (ref. I–II) | ||||||
II | 3.72 | 1.94–7.88 | <0.001 | 2.97 | 1.45–6.10 | 0.003 |
IV | 7.81 | 4.16–16.3 | <0.001 | 4.96 | 2.33–10.5 | <0.001 |
Preoperative CT (ref. no) | ||||||
Yes | 1.96 | 1.28–2.92 | 0.002 | 1.27 | 0.81–1.98 | 0.295 |
Postoperative RT (ref. no) | ||||||
Yes | 1.18 | 0.81–1.72 | 0.377 | 1.05 | 0.72–1.54 | 0.793 |
Parameters . | Univariable . | Multivariable . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Age (ref. <70 years) | ||||||
≥70 | 1.14 | 0.71–1.76 | 0.563 | |||
Gender (ref. male) | ||||||
Female | 0.82 | 0.54–1.20 | 0.300 | |||
Histological type (ref. LG-TC) | ||||||
HG-TC | 1.35 | 0.65–2.49 | 0.391 | |||
NOS-TC | 1.20 | 0.73–1.88 | 0.446 | |||
Resection status (ref. R2 non-resection) | ||||||
R0 | 0.16 | 0.09–0.28 | <0.001 | 0.27 | 0.15–0.48 | <0.001 |
R1 | 0.42 | 0.23–0.77 | <0.001 | 0.40 | 0.22–0.74 | 0.004 |
R2 sub-total | 0.43 | 0.22–0.81 | <0.001 | 0.38 | 0.20–0.72 | 0.003 |
Pathological Masaoka stage (ref. I–II) | ||||||
II | 3.72 | 1.94–7.88 | <0.001 | 2.97 | 1.45–6.10 | 0.003 |
IV | 7.81 | 4.16–16.3 | <0.001 | 4.96 | 2.33–10.5 | <0.001 |
Preoperative CT (ref. no) | ||||||
Yes | 1.96 | 1.28–2.92 | 0.002 | 1.27 | 0.81–1.98 | 0.295 |
Postoperative RT (ref. no) | ||||||
Yes | 1.18 | 0.81–1.72 | 0.377 | 1.05 | 0.72–1.54 | 0.793 |
OS: overall survival; HR: hazard ratio; CI: confidence interval; LG-TC: low-grade thymic carcinoma; HG-TC: high-grade thymic carcinoma; NOS-TC: thymic carcinoma, not otherwise specified; CT: chemotherapy; RT: radiotherapy.
Parameters . | Univariable . | Multivariable . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Age (ref. <70 years) | ||||||
≥70 | 1.14 | 0.71–1.76 | 0.563 | |||
Gender (ref. male) | ||||||
Female | 0.82 | 0.54–1.20 | 0.300 | |||
Histological type (ref. LG-TC) | ||||||
HG-TC | 1.35 | 0.65–2.49 | 0.391 | |||
NOS-TC | 1.20 | 0.73–1.88 | 0.446 | |||
Resection status (ref. R2 non-resection) | ||||||
R0 | 0.16 | 0.09–0.28 | <0.001 | 0.27 | 0.15–0.48 | <0.001 |
R1 | 0.42 | 0.23–0.77 | <0.001 | 0.40 | 0.22–0.74 | 0.004 |
R2 sub-total | 0.43 | 0.22–0.81 | <0.001 | 0.38 | 0.20–0.72 | 0.003 |
Pathological Masaoka stage (ref. I–II) | ||||||
II | 3.72 | 1.94–7.88 | <0.001 | 2.97 | 1.45–6.10 | 0.003 |
IV | 7.81 | 4.16–16.3 | <0.001 | 4.96 | 2.33–10.5 | <0.001 |
Preoperative CT (ref. no) | ||||||
Yes | 1.96 | 1.28–2.92 | 0.002 | 1.27 | 0.81–1.98 | 0.295 |
Postoperative RT (ref. no) | ||||||
Yes | 1.18 | 0.81–1.72 | 0.377 | 1.05 | 0.72–1.54 | 0.793 |
Parameters . | Univariable . | Multivariable . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
Age (ref. <70 years) | ||||||
≥70 | 1.14 | 0.71–1.76 | 0.563 | |||
Gender (ref. male) | ||||||
Female | 0.82 | 0.54–1.20 | 0.300 | |||
Histological type (ref. LG-TC) | ||||||
HG-TC | 1.35 | 0.65–2.49 | 0.391 | |||
NOS-TC | 1.20 | 0.73–1.88 | 0.446 | |||
Resection status (ref. R2 non-resection) | ||||||
R0 | 0.16 | 0.09–0.28 | <0.001 | 0.27 | 0.15–0.48 | <0.001 |
R1 | 0.42 | 0.23–0.77 | <0.001 | 0.40 | 0.22–0.74 | 0.004 |
R2 sub-total | 0.43 | 0.22–0.81 | <0.001 | 0.38 | 0.20–0.72 | 0.003 |
Pathological Masaoka stage (ref. I–II) | ||||||
II | 3.72 | 1.94–7.88 | <0.001 | 2.97 | 1.45–6.10 | 0.003 |
IV | 7.81 | 4.16–16.3 | <0.001 | 4.96 | 2.33–10.5 | <0.001 |
Preoperative CT (ref. no) | ||||||
Yes | 1.96 | 1.28–2.92 | 0.002 | 1.27 | 0.81–1.98 | 0.295 |
Postoperative RT (ref. no) | ||||||
Yes | 1.18 | 0.81–1.72 | 0.377 | 1.05 | 0.72–1.54 | 0.793 |
OS: overall survival; HR: hazard ratio; CI: confidence interval; LG-TC: low-grade thymic carcinoma; HG-TC: high-grade thymic carcinoma; NOS-TC: thymic carcinoma, not otherwise specified; CT: chemotherapy; RT: radiotherapy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.